Skip to main content
Fig. 3 | Molecular Cancer

Fig. 3

From: The m6A RNA methylation regulates oncogenic signaling pathways driving cell malignant transformation and carcinogenesis

Fig. 3

Prospect of targeting m6A regulators in developing novel cancer therapeutics. m6A RNA modification contributes to tumor progression and/or recurrence by modulating multiple cellular oncogenic signaling pathways. Targeting m6A regulatory proteins with selective molecules may interfere with the expression of m6A regulatory proteins changing the m6A status of the target signaling molecules there by blocking or activating the oncogenic or tumor-suppressive signaling pathways which may stem cancer progression or tame the therapeutically refractory tumors. CSC: Cancer Stem Cell

Back to article page

Molecular Cancer

ISSN: 1476-4598